[Collaborator's Work] Intratumoral and Stromal CD4+ T Cell Density as Predictor of pCR in TNBC

OOTR
Jun 24, 2022
1 min read

Immune Microenvironment, Homologous Recombination Deficiency, and Therapeutic Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer: Japan Breast Cancer Research Group (JBCRG)22 TR

by Takayuki Ueno, Shinji Ohno, Masakazu Toi, and colleagues

Click the link below to read more:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036790/

Recent Posts

See All

SABCS 2022 Link to Access OOTR-N016 Trial Results

The results of the OOTR-N016/KBCRN-B-003/PAB-HT trial (NCT03969121) have been made available at the 2022 San Antonio Breast Cancer...

OOTR-N016 Trial Results to be Presented at SABCS 2022

The results of the OOTR-N016/KBCRN-B-003/PAB-HT trial (NCT03969121) are going to be presented at the 2022 San Antonio Breast Cancer...

[Collaborator's Work] Ribociclib plus Endocrine Therapy in MONALEESA-7: Updated OS Data

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with...

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.

+852 2117 8011

info@ootr.org

[Collaborator's Work] Intratumoral and Stromal CD4+ T Cell Density as Predictor of pCR in TNBC

Recent Posts

Comments